1 reports of this reaction
9.1% of all HYOSCYAMUS NIGER reports
#1 most reported adverse reaction
ABNORMAL BEHAVIOUR is the #1 most commonly reported adverse reaction for HYOSCYAMUS NIGER, manufactured by Amneal Pharmaceuticals LLC. There are 1 FDA adverse event reports linking HYOSCYAMUS NIGER to ABNORMAL BEHAVIOUR. This represents approximately 9.1% of all 11 adverse event reports for this drug.
Patients taking HYOSCYAMUS NIGER who experience abnormal behaviour should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABNORMAL BEHAVIOUR is moderately reported among HYOSCYAMUS NIGER users, representing a notable but not dominant share of adverse events.
In addition to abnormal behaviour, the following adverse reactions have been reported for HYOSCYAMUS NIGER:
The following drugs have also been linked to abnormal behaviour in FDA adverse event reports:
ABNORMAL BEHAVIOUR has been reported as an adverse event in 1 FDA reports for HYOSCYAMUS NIGER. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABNORMAL BEHAVIOUR accounts for approximately 9.1% of all adverse event reports for HYOSCYAMUS NIGER, making it one of the most commonly reported side effect.
If you experience abnormal behaviour while taking HYOSCYAMUS NIGER, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.